Immunization of patients with tumors expressing NY-ESO-1 or LAGE antigen with complex of NY-ESO-1 protein and cholesterol-bearing hydrophobized pullulan (CHP).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine NY-ESO-1 (Primary)
- Indications Cancer
- Focus Pharmacodynamics
- 05 Nov 2010 Biomarkers information updated
- 20 Sep 2007 The expected completion date for this trial is now 1 Dec 2006.
- 21 Aug 2007 Status change from recruiting to completed.